SCHEMBL23917237

SCHEMBL23917237

NC(=O)c1cccc(-c2n[nH]c3ncnc(N)c23)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 4/20 0.57
TTK P33981 2/20 0.57
PIM1 P11309 2/20 0.49
MAPK8 P45983 3/20 0.48
LIMK1 P53667 3/20 0.46
LIMK2 P53671 1/20 0.46
KDR P35968 3/20 0.46
TEK Q02763 1/20 0.46
MAPK10 P53779 1/20 0.45
MAPK14 Q16539 1/20 0.45
PIK3CD O00329 2/20 0.45
PIK3CA P42336 2/20 0.45
PIK3CB P42338 2/20 0.45
PIK3CG P48736 2/20 0.45
PRKDC P78527 2/20 0.45
ABL1 P00519 2/20 0.45
EGFR P00533 2/20 0.45
HCK P08631 1/20 0.45
SRC P12931 1/20 0.45
MTOR P42345 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23917241 0.89 PIK3CD (0.57) MAP2K4TTKMAPK8KDRPIK3CD
SCHEMBL22276018 0.83 LRRK2 (0.55) MAPK8KDRMAPK10MAPK14LRRK2
SCHEMBL11405 0.81 PIK3CG (0.61) MAP2K4TTKLIMK1KDRPIK3CD
SCHEMBL30387156 0.81 PIK3CD (0.59) LIMK1PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20093467 0.80 JAK2 (0.52) KDRPIK3CDPIK3CAABL1MTOR
SCHEMBL30386858 0.79 PIK3CD (0.61) KDRTEKPIK3CDPIK3CAPIK3CB
SCHEMBL10855 0.79 MAP4K4 (0.49) MAP2K4PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL16665784 0.78 PIK3CD (0.55) MAP2K4LIMK1KDRPIK3CDPIK3CA
SCHEMBL408618 0.77 PIK3CD (0.55) TTKMAPK8LIMK1KDRMAPK10
SCHEMBL30387445 0.77 PIK3CD (0.67) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317140-A1 Heterocyclic Compounds and Methods of Use MEDIVATION TECHNOLOGIES, INC. (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317140-A1 Heterocyclic Compounds and Methods of Use BTK, PIK3CD, PIK3CB MAP2K4 141/4885TTK 81/4885PIM1 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.